ViroKine
Latest Information Update: 16 Jul 2016
At a glance
- Originator GeneTrol Biotherapeutics
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Viral infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Viral-infections in USA
- 29 Oct 2001 Preclinical development for Viral infections in USA (Unknown route)